| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |